News | EP Lab | June 25, 2024

Heart Hospital of New Mexico at Lovelace Medical Center and GE HealthCare Collaborate to Install the First Allia IGS Pulse Electrophysiology Lab in the United States for Minimally Invasive Cardiovascular Procedures

HHNM will use the Allia IGS Pulse system in its cardiac electrophysiology (EP) lab

June 25, 2024 — Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) and GE HealthCare (announced HHNM as the first location in the United States to install GE HealthCare’s latest Allia Image Guided System (IGS) Pulse, which was designed to provide exceptional image quality and improve workflow for the diagnosis and treatment of cardiovascular diseases (CVD). HHNM will use the Allia IGS Pulse system in its cardiac electrophysiology (EP) lab to plan, guide and monitor the outcomes of electrophysiological procedures, such as cardiac ablations, cardiac catherizations, transcatheter aortic valve replacements, balloon and coronary angioplasties and more.

“This advanced imaging technology allows me and my fellow clinicians to perform complex cardiology interventions with a high level of precision and exceptional image quality,” said Sean Mazer, M.D., FHRS, FACC, electrophysiologist and president of the New Mexico Heart Institute/Lovelace Medical Group*. “We can accommodate patients of any size and the system provides us with a personalized workspace that meets our specific needs and preferences, resulting in shorter surgical time and better outcomes for our patients.”

According to the 2024 Heart Disease and Stroke Statistics: A Report of U.S. and Global Data From the American Heart Association, heart disease has been the leading cause of death in the U.S. for one hundred years – with nearly half (48.6%) of all people over the age of 20 years old having some type of cardiovascular disease (CVD), including coronary heart disease, heart failure, stroke and, most notably, high blood pressure.

“It’s an honor to have the U.S.’s first Allia IGS Pulse system at Heart Hospital of New Mexico,” said Brian Miller, chief executive officer of HHNM*. “As New Mexico’s only hospital dedicated exclusively to care of the heart, we pride ourselves on providing innovative treatment options for our patients, keeping them close to home for care.”

HHNM clinicians are equipped with an adaptable, versatile solution for a wide range of clinical situations and procedures. The Allia IGS Pulse system is designed to help improve clinician workflow while also providing exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size - including large and bariatric patients with a BMI of greater than 30.

“GE HealthCare has had a long-standing relationship with Lovelace Health System and has witnessed its ongoing leadership in providing the best possible care to its patients," said Arnaud Marie, General Manager for Interventional at GE HealthCare. “We are delighted to collaborate with them for the first U.S. installation of the Allia IGS Pulse System. This next step is a demonstration of our commitment to addressing today’s healthcare challenges, unlocking efficiencies, and most importantly, providing optimal experiences for patients and their providers.”

For more information: www.gehealthcare.com


Related Content

News

May 15, 2024 —CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac ...

Home May 15, 2024
Home
News

May 13, 2024 — Innovative Health, Inc. announced that recent growth in single-use device reprocessing has delivered ...

Home May 13, 2024
Home
News

October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6 ...

Home October 10, 2023
Home
News

August 9, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) ...

Home August 09, 2023
Home
News

January 31, 2023 —Imricor, a global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation ...

Home January 31, 2023
Home
News

December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias ...

Home December 21, 2022
Home
News

October 24, 2022 — Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac ...

Home October 24, 2022
Home
News

May 13, 2022 — Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are ...

Home May 13, 2022
Home
News

May 4, 2022 – Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias ...

Home May 04, 2022
Home
News

April 5, 2021 — Acutus Medical today announced initial U.S. enrollments in the company’s AcQForce Flutter ...

Home April 05, 2021
Home
Subscribe Now